Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd W Miller

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Breast Cancer|July 13, 2017
P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic SiteJonathan D Marotti, Kristen E Muller, Laura J Tafe, et al.
Breast Cancer Research : BCR|July 13, 2013
Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivationEmily M Fox, María Gabriela Kuba, Todd W Miller, et al.
Frontiers in Microbiology|May 4, 2013
Who possesses drug resistance genes in the aquatic environment?: sulfamethoxazole (SMX) resistance genes among the bacterial community in water environment of Metro-Manila, PhilippinesSatoru Suzuki, Mitsuko Ogo, Todd W Miller, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 30, 2008
Aromatase is phosphorylated in situ at serine-118Todd W Miller, Incheol Shin, Norio Kagawa, et al.
The American Journal of Pathology|November 3, 2018
Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based TestingKevin Shee, Kristen E Muller, Jonathan Marotti, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 12, 2017
Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancerWei Yang, Sarah R Hosford, Nicole A Traphagen, et al.
Epigenomics|February 15, 2024
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
Oncotarget|March 7, 2018
Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancerWei Yang, Gary N Schwartz, Jonathan D Marotti, et al.
Oncogene|April 20, 2021
High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancerNicole A Traphagen, Sarah R Hosford, Amanda Jiang, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Breast Cancer|July 13, 2017
P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic SiteJonathan D Marotti, Kristen E Muller, Laura J Tafe, et al.
Breast Cancer Research : BCR|July 13, 2013
Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivationEmily M Fox, María Gabriela Kuba, Todd W Miller, et al.
Frontiers in Microbiology|May 4, 2013
Who possesses drug resistance genes in the aquatic environment?: sulfamethoxazole (SMX) resistance genes among the bacterial community in water environment of Metro-Manila, PhilippinesSatoru Suzuki, Mitsuko Ogo, Todd W Miller, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 30, 2008
Aromatase is phosphorylated in situ at serine-118Todd W Miller, Incheol Shin, Norio Kagawa, et al.
The American Journal of Pathology|November 3, 2018
Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based TestingKevin Shee, Kristen E Muller, Jonathan Marotti, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 12, 2017
Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancerWei Yang, Sarah R Hosford, Nicole A Traphagen, et al.
Epigenomics|February 15, 2024
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancerMeisam Bagheri, Min Kyung Lee, Kristen E Muller, et al.
Oncotarget|March 7, 2018
Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancerWei Yang, Gary N Schwartz, Jonathan D Marotti, et al.
Oncogene|April 20, 2021
High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancerNicole A Traphagen, Sarah R Hosford, Amanda Jiang, et al.
Pageof 9